KIDS — Orthopediatrics Cashflow Statement
0.000.00%
- $392.33m
- $431.47m
- $236.35m
Annual cashflow statement for Orthopediatrics, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | 2025 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | -16.3 | 1.26 | -21 | -37.8 | -39.6 |
| Depreciation | |||||
| Deferred Taxes | |||||
| Non-Cash Items | 6.2 | -13.3 | 9.9 | 19.4 | 24.6 |
| Discontinued Operations | |||||
| Unusual Items | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | -12.6 | -17.8 | -32.2 | -22.9 | -10.8 |
| Change in Accounts Receivable | |||||
| Change in Inventories | |||||
| Change in Prepaid Expenses | |||||
| Change in Accounts Payable | |||||
| Change in Accrued Expenses | |||||
| Change in Other Liabilities | |||||
| Net Change in Other Assets & Liabilities | |||||
| Cash from Operating Activities | -13.1 | -21.8 | -27 | -27 | -4.85 |
| Capital Expenditures | -16 | -10 | -19 | -14.9 | -11.1 |
| Purchase of Fixed Assets | |||||
| Purchase / Acquisition of Intangibles | |||||
| Other Investing Cash Flow Items | 8.6 | -103 | 60.7 | 1.75 | -32.5 |
| Acquisition of Business | |||||
| Sale/Maturity of Investment | |||||
| Purchase of Investments | |||||
| Cash from Investing Activities | -7.41 | -113 | 41.7 | -13.2 | -43.6 |
| Financing Cash Flow Items | — | -3.23 | -2 | -8.02 | -0.867 |
| Other Financing Cash Flow | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | 0.006 | 136 | 7.3 | 53.1 | 24 |
| Foreign Exchange Effects | |||||
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | -21.1 | 1.46 | 22.6 | 12.8 | -24.2 |